Shaoxing Hantai Pharmaceutical Co., Ltd., established in 2004, is a leading Chinese manufacturer and global exporter of pharmaceutical raw materials, veterinary APIs, health supplements, and nutraceutical ingredients. Headquartered in Shaoxing, Zhejiang Province, the company has carved a strong reputation for consistent quality, regulatory compliance, and innovation in the pharmaceutical supply chain.
Core Business
Hantai Pharma specializes in the development, production, and international distribution of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, animal health products, and excipients. With a global customer base spanning over 60 countries, the company serves pharmaceutical formulation companies, veterinary health manufacturers, and nutraceutical brands with high-grade bulk materials.
Product and Service Offerings
The company's extensive portfolio includes:
- Active Pharmaceutical Ingredients (APIs): Erythromycin Thiocyanate, Lincomycin Hydrochloride, Florfenicol
- Veterinary APIs: Tylosin Tartrate, Florfenicol
- Pharmaceutical Excipients: Lactose Monohydrate, Microcrystalline Cellulose
- Health & Nutrition Ingredients: Coenzyme Q10, Omega-3 Fish Oil
- Vitamins & Amino Acids: Vitamin B12, L-Lysine
- Packaging Materials: Empty Capsules, Blister Packs
- Additives & Preservatives: Sodium Benzoate, Citric Acid
- Plant Extracts: Ginkgo Biloba Extract, Green Tea Extract
- Agrochemicals: Glyphosate, Imidacloprid
- New Molecules: Semaglutide (offered for research and development purposes)
Their flexible packaging solutions and product customization options cater to diverse business needs, from large-scale bulk manufacturing to precision pharmaceutical applications.
Specialization and Unique Selling Proposition
Hantai Pharma’s USP lies in its comprehensive compliance with international pharmaceutical standards including USP, EP, BP, and JP. The company maintains long-term strategic partnerships with over 100 GMP-certified manufacturing plants across China and manages more than 2,000 validated product specifications through its internal quality systems. Its capacity to offer both human and veterinary APIs under one roof distinguishes it from other Chinese suppliers.
Moreover, the company is known for fast-tracked sourcing solutions, regulatory documentation support (such as DMFs), and supply chain reliability, making it a preferred partner for formulators and distributors worldwide.
Financial Performance
While the company is privately held and does not disclose complete financial statements, third-party industry reports indicate:
- Estimated Annual Revenue: $80–$100 million USD (based on import/export data and global supply contracts)
- Export Contribution: ~70% of total revenue is attributed to international markets, particularly in Southeast Asia, South America, MENA, and Eastern Europe
These insights are derived from customs data analytics and vendor transaction records available via platforms like ImportYeti and Volza.
International Shipments & Market Footprint
According to Volza Trade Intelligence and ImportYeti:
- Shipment Volume (Past 3 Years): Over 3,200 international consignments
- Key Export Destinations: India, Egypt, Brazil, Bangladesh, Indonesia, and Vietnam
- Top Exported Products: Florfenicol, Lincomycin HCl, Erythromycin derivatives, Vitamin B12
The consistency in shipment volume and product diversity reflects robust demand and high customer retention.
Target Markets
Hantai Pharma targets:
- Generic pharmaceutical manufacturers
- Veterinary pharmaceutical companies
- Nutraceutical and dietary supplement brands
- Contract manufacturers and CDMOs
- Global importers and bulk API distributors
Their presence is particularly strong in developing markets with growing healthcare demand and cost-sensitive formulations.
Capabilities
- Strategic Procurement Network: Partnership with 100+ GMP manufacturers in China
- Regulatory Support: COAs, MSDS, DMFs, COPPs, CEPs available for a wide range of APIs
- Custom Synthesis & Sourcing: New molecule R&D support including for complex generics
- Packaging & Logistics: Customized bulk packing, fast dispatch from Shanghai/Ningbo ports
- Multilingual Team: Export team fluent in English, Spanish, and Russian for client engagement
Certifications and Compliance
- ISO 9001:2015 Certified
- GMP compliance across partner facilities
- Products meet USP/EP/BP/JP pharmacopeial standards
- In-house QA/QC laboratories for testing, validation, and documentation
The company also provides comprehensive dossiers to clients in regulated markets upon request.
Customer Testimonials
"We’ve been sourcing APIs from Hantai for over 5 years. Their consistency in quality and timely documentation support has helped us with regulatory submissions in multiple markets."
— Procurement Director, Indian Formulations Company
"Florfenicol and Lincomycin from Hantai have proven to be high purity and cost-effective for our veterinary line. Highly recommend them for volume buyers."
— CEO, Animal Health Products Importer, Egypt
Major Achievements
- Export presence in over 60 countries with a 95% on-time delivery rate
- Introduced over 20 new molecules for R&D and clinical trial supply since 2020
- Participated in leading global trade shows such as CPhI Worldwide and VIV Asia
- Developed a proprietary QC module integrated with its ERP system for batch traceability and audit readiness
Shaoxing Hantai Pharmaceutical Co., Ltd. continues to grow as a dynamic, agile partner for pharmaceutical buyers worldwide—blending Chinese manufacturing strengths with international business standards.
